<?xml version="1.0" encoding="UTF-8"?>
<p>The inhibition studies were conducted with the use of a biolayer interferometry (BLI) assay.
 <sup>
  <xref ref-type="bibr" rid="ref4">4</xref>
 </sup> In this assay a streptavidin coated sensor was loaded with a sialylated glycoprotein LAMP1. Influenza A virus WU95 (containing a H3 protein of a human H3N2 virus; see 
 <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.9b00303/suppl_file/jm9b00303_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Supporting Information</ext-link>) was used, and its binding to the sensor could readily be observed. Performing the experiment in the presence of the inhibitors clearly showed inhibition (
 <xref rid="fig3" ref-type="fig">Figure 
  <xref rid="fig3" ref-type="fig">3</xref>
 </xref>a). By use of a range of concentrations for each compound, inhibition curves were obtained (
 <xref rid="fig3" ref-type="fig">Figure 
  <xref rid="fig3" ref-type="fig">3</xref>
 </xref>B) and the results were quantified (
 <xref rid="tbl1" ref-type="other">Table 
  <xref rid="tbl1" ref-type="other">1</xref>
 </xref>).
</p>
